Yuanjin Zhang

1.2k total citations · 1 hit paper
56 papers, 736 citations indexed

About

Yuanjin Zhang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yuanjin Zhang has authored 56 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Yuanjin Zhang's work include Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Yuanjin Zhang is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Yuanjin Zhang collaborates with scholars based in China, United States and Singapore. Yuanjin Zhang's co-authors include Xin Wang, Mingyao Liu, Jian Lu, Yuwu Chi, Guonan Chen, Lichan Chen, Dali Li, Yuanqing Guo, Yuxuan Wu and Jiaoyang Liao and has published in prestigious journals such as Nature Medicine, Nature Communications and Analytical Chemistry.

In The Last Decade

Yuanjin Zhang

54 papers receiving 728 citations

Hit Papers

CRISPR–Cas9-mediated gene editing of the BCL11A enhancer ... 2022 2026 2023 2024 2022 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
    2022 109 citations Bin Fu, Jiaoyang Liao et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanjin Zhang China 18 368 127 94 85 81 56 736
Lijuan Yu China 17 914 2.5× 92 0.7× 130 1.4× 47 0.6× 47 0.6× 31 1.4k
Yu Tian China 20 674 1.8× 200 1.6× 144 1.5× 28 0.3× 56 0.7× 60 1.4k
Qingwu Tian China 16 400 1.1× 58 0.5× 85 0.9× 37 0.4× 23 0.3× 48 828
Lujie Yang China 11 308 0.8× 104 0.8× 31 0.3× 125 1.5× 123 1.5× 28 783
Zeliang Wei China 18 431 1.2× 63 0.5× 112 1.2× 42 0.5× 42 0.5× 63 997
Yao Tong China 20 578 1.6× 50 0.4× 80 0.9× 68 0.8× 18 0.2× 33 1.0k
Zhiling Zhou China 14 380 1.0× 119 0.9× 47 0.5× 32 0.4× 24 0.3× 50 861
Silu Wang China 18 453 1.2× 332 2.6× 46 0.5× 12 0.1× 41 0.5× 35 1.1k
Huizi Wu China 15 285 0.8× 101 0.8× 68 0.7× 38 0.4× 27 0.3× 44 707

Countries citing papers authored by Yuanjin Zhang

Since Specialization
Citations

This map shows the geographic impact of Yuanjin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanjin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanjin Zhang more than expected).

Fields of papers citing papers by Yuanjin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanjin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanjin Zhang. The network helps show where Yuanjin Zhang may publish in the future.

Co-authorship network of co-authors of Yuanjin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanjin Zhang. A scholar is included among the top collaborators of Yuanjin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanjin Zhang. Yuanjin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jun, et al.. (2025). MiR-103-3p regulates chondrocyte autophagy, apoptosis, and ECM degradation through the PI3K/Akt/mTOR pathway by targeting CPEB3. Journal of Orthopaedic Surgery and Research. 20(1). 324–324. 2 indexed citations
2.
3.
Lu, Na, et al.. (2025). CYP3A mediates drug-drug interactions between atorvastatin and omeprazole: Evidence from in vitro and in vivo studies. Biochemical Pharmacology. 242(Pt 1). 117241–117241.
4.
5.
6.
Zhang, Yanfang, et al.. (2024). Sorafenib reduces the production of epoxyeicosatrienoic acids and leads to cardiac injury by inhibiting CYP2J in rats. Biochemical Pharmacology. 223. 116169–116169. 1 indexed citations
7.
Wu, Xin, Meiyan Wang, Di Dai, et al.. (2024). AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature Communications. 15(1). 1122–1122. 8 indexed citations
8.
Guo, Yuanqing, Yuanjin Zhang, Haichuan Li, et al.. (2024). Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport. Toxicology and Applied Pharmacology. 492. 117112–117112. 3 indexed citations
9.
Liao, Jiaoyang, Yang Yang, Yuanjin Zhang, et al.. (2023). Therapeutic adenine base editing of human hematopoietic stem cells. Nature Communications. 14(1). 207–207. 37 indexed citations
10.
Li, Jun, et al.. (2023). Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR‐433‐3p and Targeting OMA1. Orthopaedic Surgery. 15(4). 1060–1071. 3 indexed citations
11.
Liu, Jie, Jian Lu, Yuanjin Zhang, et al.. (2023). Construction of Humanized CYP1A2 Rats Using CRISPR/CRISPR-Associated Protein 9 to Promote Drug Metabolism and Pharmacokinetic Research. Drug Metabolism and Disposition. 52(1). 56–62. 2 indexed citations
12.
Sharma, Tanu, et al.. (2023). Dimethyl fumarate inhibits ZNF217 and can be beneficial in a subset of estrogen receptor positive breast cancers. Breast Cancer Research and Treatment. 201(3). 561–570. 1 indexed citations
13.
Fu, Bin, Jiaoyang Liao, Shuanghong Chen, et al.. (2022). CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia. Nature Medicine. 28(8). 1573–1580. 109 indexed citations breakdown →
14.
Wang, Xu, Xu Wang, Yuanjin Zhang, et al.. (2022). Evaluation of Herb–Drug Interaction Between Danshen and Rivaroxaban in Rat and Human Liver Microsomes. Frontiers in Pharmacology. 13. 950525–950525. 5 indexed citations
15.
Jin, Yunyun, Qianqian Liu, Peng Chen, et al.. (2022). A novel prostaglandin E receptor 4 (EP4) small molecule antagonist induces articular cartilage regeneration. Cell Discovery. 8(1). 24–24. 29 indexed citations
16.
Xu, Yuan, Jian Lu, Yuanjin Zhang, et al.. (2021). P-glycoprotein mediates the pharmacokinetic interaction of olanzapine with fluoxetine in rats. Toxicology and Applied Pharmacology. 431. 115735–115735. 4 indexed citations
17.
Xu, Yuan, Yi Cheng, Zhenliang Sun, et al.. (2020). Assessment of the inhibition risk of paris saponins, bioactive compounds from Paris polyphylla, on CYP and UGT enzymes via cocktail inhibition assays. Regulatory Toxicology and Pharmacology. 113. 104637–104637. 6 indexed citations
18.
Zhao, Junfang, Jian Lu, Yuanjin Zhang, et al.. (2018). Development and Characterization of MDR1 (Mdr1a/b) CRISPR/Cas9 Knockout Rat Model. Drug Metabolism and Disposition. 47(2). 71–79. 20 indexed citations
19.
Zhou, Zhen, Yuanjin Zhang, Haixiang Pei, et al.. (2018). Design, synthesis and evaluation of hybrid of tetrahydrocarbazole with 2,4-diaminopyrimidine scaffold as antibacterial agents. European Journal of Medicinal Chemistry. 162. 203–211. 21 indexed citations
20.
Song, Shujuan, Yuanzhi Zhang, Biao Chen, et al.. (2006). Mutation frequency for Charcot-Marie-Tooth disease type 1 in the Chinese population is similar to that in the global ethnic patients. Genetics in Medicine. 8(8). 532–535. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijuan Yu Breakdown of academic impact, for papers by Yu Tian Breakdown of academic impact, for papers by Qingwu Tian Breakdown of academic impact, for papers by Lujie Yang Breakdown of academic impact, for papers by Zeliang Wei Breakdown of academic impact, for papers by Yao Tong Breakdown of academic impact, for papers by Zhiling Zhou Breakdown of academic impact, for papers by Silu Wang Breakdown of academic impact, for papers by Huizi Wu
Rankless by CCL
2026